Regulatory Gaps in 'Bulk Preparation of Herbal Medicine' Reignited by Jaseng Hospital of Korean Medicine Controversy
No Clear Criteria for Bulk Preparation
Outsourced Decoction Facility Records
Not Included in Claim Documents
Oversight Authority Also Fragmented Across Ministries
Jaseng Hospital of Korean Medicine, which operates the largest integrated Korean medicine compounding facility in the country, has come under police investigation for allegedly preparing large quantities of herbal medicine in advance. This incident has once again highlighted the regulatory loopholes surrounding the compounding of herbal prescriptions in Korean medicine.
The herbal prescriptions in question, covered by auto insurance, are only eligible for reimbursement if they are individually diagnosed and compounded according to each patient’s symptoms and constitution. Pre-compounding in bulk refers to preparing specific prescriptions in advance and distributing them uniformly to patients before any diagnosis is made. This practice has been criticized for contradicting the principle of individualized compounding. However, 'pre-compounding'—which involves preparing ingredients in advance—is permitted under legal precedents. The problem lies in the ambiguous boundary between pre-compounding and bulk pre-compounding; there is no clear basis for determining what is legal and what is not.
According to the insurance and medical industries on July 13, Samsung Fire & Marine Insurance, Hyundai Marine & Fire Insurance, KB Insurance, and DB Insurance jointly filed a complaint, alleging that Jaseng Hospital of Korean Medicine fraudulently billed insurance companies for hundreds of billions of won by claiming that herbal medicines mass-produced in advance were individually compounded for each patient. The auto insurance medical billing standards stipulate that herbal prescriptions for traffic accident patients are only recognized if they are compounded and prescribed individually, according to the patient’s symptoms and severity of the disease.
This means that individual compounding based on patient diagnosis is a prerequisite for insurance coverage. The non-life insurance industry cited this provision as the basis for their complaint against Jaseng Hospital of Korean Medicine.
Pre-compounding Permitted... The Boundary with Bulk Compounding Remains 'Ambiguous'
Pre-compounding itself is not illegal. The issue is the lack of clear standards distinguishing between lawful pre-compounding and unlawful bulk compounding. According to Supreme Court precedents, pre-compounding—where ingredients are prepared in advance based on anticipated prescriptions for better efficacy management and compounding efficiency—is permitted.
A Ministry of Health and Welfare official stated, "Simply preparing medicine in advance does not automatically make it illegal or constitute an unjust claim," but added, "Factory-style pre-compounding is problematic." However, when asked about the boundary, the official said, "Whether 10 or 100 is considered bulk is subjective." Another ministry official commented, "Since the precedent does not limit pre-compounding to specific diseases or prescriptions, it should not be interpreted narrowly."
The tendency for traffic accident prescriptions to become similar also makes differentiation challenging. A representative from a Korean medicine association, speaking on condition of anonymity, said, "Because patients are clustered within a narrow category of pain, prescriptions tend to converge on 20 to 30 representative formulas," and added, "Similar prescriptions do not necessarily indicate bulk pre-compounding." The representative further explained, "If the external compounding facility records the compounding date and time down to the second for each patient, that could serve as evidence for individualized compounding."
The compounding records needed for assessment are not collected in real time. According to the Health Insurance Review and Assessment Service, which reviews auto insurance medical expenses, external compounding facilities are not subject to auto insurance claims, and when submitting herbal prescription claims, only the type of compounding (in-house, joint use, or other) is included in the prescription and compounding report. There is no data at the claims stage to determine whether prescriptions were individualized.
Currently, the Ministry of Health and Welfare is responsible for certifying external compounding facilities and operations, the Health Insurance Review and Assessment Service evaluates the appropriateness of individual prescriptions, and the Ministry of Land, Infrastructure and Transport announces the medical fee schedule. The Health Insurance Review and Assessment Service designated herbal prescriptions as a focused review item for 2024 and has been intensively reviewing 'institutions suspected of bulk prescribing and compounding' since November last year, but it only has the authority to make reductions or adjustments, not to impose administrative penalties. The Ministry of Health and Welfare conducts annual evaluations of external compounding facilities through a certification system, but says that the specifics of individualized prescriptions fall under the purview of the Health Insurance Review and Assessment Service, so it does not conduct separate inspections.
Medical expenses for Korean medicine under auto insurance have steadily increased in recent years, driven by the inclusion of herbal prescriptions, herbal acupuncture, and manual therapy as covered items. In the National Assembly, a proposed amendment to the Automobile Damage Compensation Guarantee Act, which would provide grounds for on-site investigations by the Health Insurance Review and Assessment Service and penalties for violations of cooperation obligations, has been introduced.
Certification of external compounding facilities is a voluntary rather than mandatory system. During last year's National Assembly audit, it was pointed out that participation in certification should be increased and management of compounding personnel should be strengthened. The Ministry of Health and Welfare is conducting a comprehensive study to improve the external compounding facility system, with completion targeted for December this year.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Meanwhile, Jaseng Hospital of Korean Medicine has stated regarding this investigation that the allegation of "indiscriminately prescribing factory-made herbal medicine to traffic accident patients" is not true.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.